Skip to main content

GeneDx Holdings Corp 10-Q for FY2024 Q1

GeneDx Holdings Corp. (WGS)

10-Q 2024-04-29 For: 2024-03-31
View Original
Added on April 07, 2026

About this 10-Q

GeneDx Holdings Corp filed this 10-Q on April 29, 2024, covering the quarter ended March 31, 2024 (FY2024 Q1).

Headline figures

Quarter ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$62.42M
up 44.7% from $43.14M a year earlier
Net loss
$20.24M
compared with a net loss of $60.99M a year earlier
Diluted EPS
-$0.78
compared with -$3.04 a year earlier